Skip to main content
. Author manuscript; available in PMC: 2010 May 6.
Published in final edited form as: J Pharmacol Exp Ther. 1999 Apr;289(1):378–385.

Fig. 3.

Fig. 3

Antagonist effects of quadazocine administered locally in the tail and systemically in the back against local U50,488 in 46°C water in the presence of capsaicin. The label cap + U50 represents the effects of coadministration of 0.1 mg of capsaicin and 100 μg of U50,488 in the tail. Other details are as in Fig. 1.